Journal of Bone Metabolism

CrossRef Text and Data Mining

Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.

Insufficient Mitigation of Bone Loss by Zoledronic Acid after Treatment with Denosumab

Jung-Wee Park

jbm. 2021;28(4):339-341. Published online November 30, 2021
DOI: https://doi.org/10.11005/jbm.2021.28.4.339

Insufficient Mitigation of Bone Loss by Zoledronic Acid after Treatment with Denosumab

Jung-Wee Park

Journal of Bone Metabolism. 2021;28(4):339-341

Link1

Link2 Link3

Zoledronic Acid after Treatment with Denosumab is Associated with Bone Loss within 1 Year

Tarun Kadaru, Amal Shibli-Rahhal

Journal of Bone Metabolism. 2021;28(1):51-58

Link1

Link2 Link3

OR13-02 Treatment with Zoledronic Acid Subsequent to Denosumab Cannot Fully Prevent Bone Loss

Anne Sophie K Sølling, Torben Harsløf, Bente Lomholt Langdahl

Journal of the Endocrine Society. 2020;4(Supplement_1):

Link1

Link2

Bone metastases, clinical trials II: zoledronic acid and denosumab in the prevention of bone metastases

Michael Gnant

Bone Cancer. 2015;685-689

Link1 Link2

Denosumab after bone progression with zoledronic acid: a single center experience

D. Pastorelli, S. Zovato, C. Soldà

Annals of Oncology. 2015;26:vi122

Link1 Link2 Link3

Zoledronic Acid Infusions Cut Treatment-Related Bone Loss

BRUCE JANCIN

Ob.Gyn. News. 2008;43(5):15

Link1 Link2

Comparative Safety and Effectiveness of Denosumab Versus Zoledronic Acid in Patients With Osteoporosis: A Cohort Study

Nam-Kyong Choi, Daniel H Solomon, Theodore N Tsacogianis, Joan E Landon, Hong Ji Song, Seoyoung C Kim

Journal of Bone and Mineral Research. 2017;32(3):611-617

Link1 Link2 Link3

Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: A randomised, double-blind study

A.S. Kibel

Yearbook of Urology. 2011;2011:74-75

Link1 Link2

1016: Randomized Trial of Denosumab Versus Zoledronic Acid in Prostate Cancer Patients with Bone Metastases and Elevated Bone Turnover Markers After Receiving Zoledronic Acid Therapy

Linda Bosserman, Karim Fizazi, Allan Lipton, Yasmin Rahim, Tirzo Suarez, Michelle Fan, Ling Wu, Richard A. Markus

Journal of Urology. 2007;177(4S):335-336

Link1 Link2

Marrow adiposity recovery after early zoledronic acid treatment of glucocorticoid-induced bone loss in rabbits assessed by magnetic resonance spectroscopy

Guan-Wu Li, Shi-Xin Chang, Jing-Zheng Fan, Ya-Nan Tian, Zheng Xu, Yan-Ming He

Bone. 2013;52(2):668-675

Link1 Link2